Success Stories

Event Videos

Seamless Management of Juvenile Autoimmune Liver Disease: Long-Term Medical and Social Outcome. https://www.ncbi.nlm.nih.gov/pubmed/31955873 Autoimmune hepatitis J Pediatr. 2020 Jan 16. pii: S0022-3476(19)31609-9. doi: 10.1016/j.jpeds.2019.11.028. [Epub ahead of print] Seamless Management of Juvenile Autoimmune Liver Disease: Long-Term Medical and Social Outcome. Di Giorgio A1, Hadzic N2, Dhawan A2, Deheragoda M3, Heneghan MA4, Vergani D5, Mieli-Vergani G6, Samyn M2. Abstract OBJECTIVES: To report baseline features and long-term medical/social outcomes of juvenile autoimmune liver disease, including autoimmune hepatitis (AIH) and autoimmune sclerosing cholangitis (ASC), managed in a single tertiary center. STUDY DESIGN: Published on: Jan-2020 Read more	Liver Transplantation for Propionic Acidemia: A Multicenter-linked Database Analysis. https://www.ncbi.nlm.nih.gov/pubmed/31978012 Propionic acidemia J Pediatr Gastroenterol Nutr. 2020 Feb;70(2):178-182. doi: 10.1097/MPG.0000000000002534. Liver Transplantation for Propionic Acidemia: A Multicenter-linked Database Analysis. Alexopoulos SP1, Matsuoka L1, Hafberg E2, Morgan T3, Thurm C4, Hall M4, Godown J5. Abstract OBJECTIVES: Published on: Jan-2020 Read more
Fasting C-peptide is a significant indicator of nonalcoholic fatty liver disease in obese children. https://www.ncbi.nlm.nih.gov/pubmed/31958476 NAFLD Diabetes Res Clin Pract. 2020 Jan 17;160:108027. doi: 10.1016/j.diabres.2020.108027. [Epub ahead of print] Fasting C-peptide is a significant indicator of nonalcoholic fatty liver disease in obese children. Han X1, Xu P2, Zhou J1, Liu Y3, Xu H4. Abstract AIMS: Whether fasting C-peptide can be a potential indicator for nonalcoholic fatty liver disease (NAFLD) in obese children is unknown. This study aimed to assess whether fasting C-peptide represented a risk factor for NAFLD. METHODS: Published on: Jan-2020 Read more	Growth in Infants and Children With Intestinal Failure-associated Liver Disease Treated With Intravenous Fish Oil. https://www.ncbi.nlm.nih.gov/pubmed/31978030 J Pediatr Gastroenterol Nutr. 2020 Feb;70(2):261-268. doi: 10.1097/MPG.0000000000002551. Growth in Infants and Children With Intestinal Failure-associated Liver Disease Treated With Intravenous Fish Oil. Raphael BP1, Mitchell PD2, Gura KM1,3, Potemkin AK4, Squires RH5, Puder M4, Duggan CP1. Author information Abstract BACKGROUND: Published on: Jan-2020 Read more
Wilson disease in children and adolescents https://www.ncbi.nlm.nih.gov/pubmed/31974298 Wilson disease Arch Dis Child. 2020 Jan 23. pii: archdischild-2018-315705. doi: 10.1136/archdischild-2018-315705. [Epub ahead of print] Wilson disease in children and adolescents. Fernando M1, van Mourik I2, Wassmer E3, Kelly D1. Abstract Published on: Jan-2020 Read more	Blood stream infections in children in the first year after liver transplantation at wits Donald Gordon Medical Centre, South Africa. https://www.ncbi.nlm.nih.gov/pubmed/31985168 Liver transplant Pediatr Transplant. 2020 Jan 27:e13660. doi: 10.1111/petr.13660. [Epub ahead of print] Blood stream infections in children in the first year after liver transplantation at wits Donald Gordon Medical Centre, South Africa. Duncan M1, DeVoll-Zabrocki A2, Etheredge HR1,3, Maher HA1, Bouter C1, Gaylard P4, Loveland J1,5, Fabian J1,3, Botha JF1,6. Abstract Published on: Jan-2020 Read more
Management of HBV Infection and Prevention of HBV Reactivation in Children with Acquired Immunodeficiencies or Undergoing Immune Suppressive, https://www.ncbi.nlm.nih.gov/pubmed/31977956 J Pediatr Gastroenterol Nutr. 2020 Jan 21. doi: 10.1097/MPG.0000000000002628. [Epub ahead of print] Management of HBV Infection and Prevention of HBV Reactivation in Children with Acquired Immunodeficiencies or Undergoing Immune Suppressive, Cytotoxic or Biological Modifier Therapies. Indolfi G1, Abdel-Hady M2, Bansal S3, Debray D4, Smets F5, Czubkowski P6, van der Woerd W7, Samyn M3, Jahnel J8, Gupte G9, Zellos A10, Mozer-Glassberg Y11, Verkade HJ12, Sokal E13, Fischler B14. Author information Abstract Published on: Jan-2020 Read more	Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune Hepatitis. https://www.ncbi.nlm.nih.gov/pubmed/31988876 Autoimmune hepatitis Pediatr Gastroenterol Hepatol Nutr. 2020 Jan;23(1):63-71. doi: 10.5223/pghn.2020.23.1.63. Epub 2020 Jan 8. Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune Hepatitis. Alsayed MAL1, Elbeah SM2, El-Desoky MM2, Elziny SM1, Megahed A1. Abstract PURPOSE: Published on: Jan-2020 Read more
Efficacy and Safety of Sodium Benzoate in The Management of Hyperammonemia in Decompensated Chronic Liver Disease of the Childhood-A Double-blind Randomized Controlled Trial. https://www.ncbi.nlm.nih.gov/pubmed/31978010 Chronic liver disease J Pediatr Gastroenterol Nutr. 2020 Feb;70(2):165-170. doi: 10.1097/MPG.0000000000002521. Efficacy and Safety of Sodium Benzoate in The Management of Hyperammonemia in Decompensated Chronic Liver Disease of the Childhood-A Double-blind Randomized Controlled Trial. Snehavardhan P1, Lal BB, Sood V, Khanna R, Alam S. Abstract OBJECTIVE: The objective was to evaluate the efficacy and safety of sodium benzoate in the management of hyperammonemia and hepatic encephalopathy (HE) in decompensated chronic liver disease. METHODS: Published on: Jan-2020 Read more	Infantile Hepatic Hemangioma: Avoiding Unnecessary Invasive Procedures. https://www.ncbi.nlm.nih.gov/pubmed/31988877 Hemangioma Pediatr Gastroenterol Hepatol Nutr. 2020 Jan;23(1):72-78. doi: 10.5223/pghn.2020.23.1.72. Epub 2020 Jan 9. Infantile Hepatic Hemangioma: Avoiding Unnecessary Invasive Procedures. Ernst L1, Grabhorn E2, Brinkert F2, Reinshagen K3, Königs I3, Trah J3. Abstract Published on: Jan-2020 Read more

CLF Intro movie

SMS requests to

9224791366

Ask The Expert

Pediatric Liver Specialists in India

Centres offering Genetic Testing for Pediatric Liver Diseases

Financial Aid Offered by Trusts

Follow us on:

Facebook Twitter YouTube